Nehls, J. ; Businger, R.* ; Hoffmann, M.* ; Brinkmann, C.* ; Fehrenbacher, B.* ; Schaller, M.* ; Maurer, B.* ; Schönfeld, C.* ; Kramer, D.* ; Hailfinger, S.* ; Pöhlmann, S.* ; Schindler, M.
Release of immunomodulatory Ebola virus glycoprotein-containingmicrovesicles is suppressed by tetherin in a species-specific manner.
Cell Rep. 26, 1841-1853.e6 (2019)
The Ebola virus glycoprotein (EBOV-GP) forms GP-containing microvesicles, so-called virosomes, which are secreted from GP-expressing cells. However, determinants of GP-virosome release and their functionality are poorly understood. We characterized GP-mediated virosome formation and delineated the role of the antiviral factor tetherin (BST2, CD317) in this process. Residues in the EBOV-GP receptor-binding domain (RBD) promote GP-virosome secretion, while tetherin suppresses GP-virosomes by interactions involving the GP-transmembrane domain. Tetherin from multiple species interfered with GP-virosome release, and tetherin from the natural fruit bat reservoir showed the highest inhibitory activity. Moreover, analyses of GP from various ebo-lavirus strains, including the EBOV responsible for the West African epidemic, revealed the most efficient GP-virosome formation by highly pathogenic ebolaviruses. Finally, EBOV-GP-virosomes were immunomodulatory and acted as decoys for EBOV-neutralizing antibodies. Our results indicate that GP-virosome formation might be a determinant of EBOV immune evasion and pathogenicity, which is suppressed by tetherin.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ebola Virus ; Antiviral Immune Response ; Exosome ; Glycoprotein ; Immune Evasion ; Immune Modulation ; Microvesicles ; Neutralizing Antibody ; Tetherin ; Virosome; Filovirus Glycoproteins; Hiv-1 Release; Cell-surface; Life-cycle; Protein; Entry; Infection; Binding; Pathogenesis; Restriction
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 26,
Issue: 7,
Pages: 1841-1853.e6
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-006
Grants
Copyright
Erfassungsdatum
2019-03-13